FTC sues drug middlemen for allegedly inflating insulin prices
Lina Khan, Chair of the Federal Trade Commission (FTC), testifies before the House Appropriations Subcommittee at the Rayburn House Office ...
Tag: Novo Nordisk A/S
Federal Trade Commission to sue drug middlemen over prices of medications including insulin, source says
Federal Trade Commission Chair Lina Khan testifies during a hearing of the House Appropriations Subcommittee on Financial Services and General ...
This ETF is trying to satisfy appetites for weight loss stocks
Tema ETFs has been capitalizing on the risk appetite for weight loss stocks.It is behind the GLP-1, Obesity & Cardiometabolic ...
This new weight loss drug ETF bets big on two of the industry’s leading players
A top exchange-traded fund provider is betting on the long-term popularity of GLP-1 weight loss drugs.Roundhill Investments' GLP-1 & Weight ...
How digital health companies are capitalizing on the GLP-1 boom
Patent protection for Wegovy — Novo Nordisk's blockbuster weight loss drug, which contains the second generation GLP-1 active ingredient and ...
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
A food delivery messenger carries a take out bag outside aSweetgreen in Manhattan on September 14, 2023.Jeenah Moon | The ...
Diabetes drug similar to Ozempic helped slow progression of Parkinson’s disease in small trial
The coronal view of a human brain of a patient suffering from Parkinson's diseaseSherbrooke Connectivity Imaging Lab | Getty ImagesA ...
Novo Nordisk’s $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. Lee Smith | ...
Two fresh ways to play the weight loss and megacap tech hype
A major exchange-traded fund provider is going deep on two popular plays: megacap tech and weight loss drug stocks.In health ...
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen. Rafael Henrique | SOPA Images | Lightrocket ...
